Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 758684, 11 pages
http://dx.doi.org/10.1155/2015/758684
Research Article

Levonorgestrel Inhibits Human Endometrial Cell Proliferation through the Upregulation of Gap Junctional Intercellular Communication via the Nuclear Translocation of Ser255 Phosphorylated Cx43

1Department of Obstetrics and Gynecology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510120, China
2Department of Obstetrics and Gynecology, Shenzhen Maternity and Child Care Centers, Southern Medical University, Shenzhen, Guangdong 518000, China
3Pathology Department, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510120, China
4Department of Obstetrics and Gynecology, The First Affiliated Hospital of Soochow University, Suzhou 215325, China

Received 12 July 2014; Revised 27 September 2014; Accepted 28 September 2014

Academic Editor: Ignacio Zapardiel

Copyright © 2015 Xiaomiao Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Minig, D. Franchi, S. Boveri, C. Casadio, L. Bocciolone, and M. Sideri, “Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women,” Annals of Oncology, vol. 22, no. 3, pp. 643–649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Haimovich, M. A. Checa, G. Mancebo, P. Fusté, and R. Carreras, “Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device,” Menopause, vol. 15, no. 5, pp. 1002–1004, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Gambadauro, M. A. Martinez-Maestre, J. Schneider, and R. Torrejon, “Malignant and premalignant changes in the endometrium of women with an ultrasound diagnosis of endometrial polyp,” Journal of Obstetrics and Gynaecology, vol. 34, no. 7, pp. 611–615, 2014. View at Google Scholar
  4. M. Arnes, B. Hvingel, and A. Orbo, “Levonorgestrel-impregnated Intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study,” Anticancer Research, vol. 34, no. 5, pp. 2319–2324, 2014. View at Google Scholar
  5. C. Saccardi, S. Gizzo, T. S. Patrelli et al., “Endometrial surveillance in tamoxifen users: role, timing and accuracy of hysteroscopic investigation: observational longitudinal cohort study,” Endocrine-Related Cancer, vol. 20, no. 4, pp. 455–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Litta, F. Merlin, C. Saccardi et al., “Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding,” Maturitas, vol. 50, no. 2, pp. 117–123, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Litta, C. Bartolucci, C. Saccardi et al., “Atypical endometrial lesions: hysteroscopic resection as an alternative to hysterectomy,” European Journal of Gynaecological Oncology, vol. 34, no. 1, pp. 51–53, 2013. View at Google Scholar · View at Scopus
  8. R. Berretta, T. S. Patrelli, C. Migliavacca et al., “Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer,” Oncology Reports, vol. 31, no. 5, pp. 2407–2412, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Gizzo, S. di Gangi, A. Bertocco et al., “Levonorgestrel intrauterine system in adjuvant tamoxifen treatment: balance of breast risks and endometrial benefits—systematic review of literature,” Reproductive Sciences, vol. 21, no. 4, pp. 423–431, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Cesen-Cummings, M. J. Fernstrom, A. M. Malkinson, and R. J. Ruch, “Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells,” Carcinogenesis, vol. 19, no. 1, pp. 61–67, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. T. J. King, L. H. Fukushima, A. D. Hieber, K. A. Shimabukuro, W. A. Sakr, and J. S. Bertram, “Reduced levels of connexin43 in cervical dysplasia: Inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression,” Carcinogenesis, vol. 21, no. 6, pp. 1097–1109, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B.-Y. Zhang, X.-W. Dai, Q.-Y. Chen et al., “Expression of epithelial-cadherin, CD44v6 and connexin43 in hepatocellular carcinoma,” Chinese Journal of Pathology, vol. 35, no. 10, pp. 616–619, 2006. View at Google Scholar · View at Scopus
  13. Z. Q. Zhang, W. Zhang, N. Q. Wang, M. Bani-Yaghoub, Z. X. Lin, and C. C. Naus, “Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43,” Carcinogenesis, vol. 19, no. 11, pp. 1889–1894, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. S. R. Schlemmer, D. B. Novotny, and D. G. Kaufman, “Changes in connexin 43 protein expression in human endometrial carcinoma,” Experimental and Molecular Pathology, vol. 67, no. 3, pp. 150–163, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Yamasaki, V. Krutovskikh, M. Mesnil, T. Tanaka, M. L. Zaidan-Dagli, and Y. Omori, “Role of connexin (gap junction) genes in cell growth control and carcinogenesis,” Comptes Rendus de l'Academie des Sciences, vol. 322, no. 2-3, pp. 151–159, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Fernstrom, L. D. Koffler, G. Abou-Rjaily, P. D. Boucher, D. S. Shewach, and R. J. Ruch, “Neoplastic reversal of human ovarian carcinoma cells transfected with Connexin43,” Experimental and Molecular Pathology, vol. 73, no. 1, pp. 54–60, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. I. P. Ryan, E. D. Schriock, and R. N. Taylor, “Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro,” The Journal of Clinical Endocrinology & Metabolism, vol. 78, no. 3, pp. 642–649, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Zhao, X. Tang, and M. Xie, “Levonorgestrel inhibits human endometrial cell proliferation through the up-regulation of gap junctional intercellular communication via the increased expression of Connexin43 and the nuclear translocation of its Ser255 phosphorylation,” Endocrine Abstracts, vol. 32, article P591, 2013. View at Publisher · View at Google Scholar
  19. J. Czyz, “The stage-specific function of gap junctions during tumourigenesis,” Cellular & Molecular Biology Letters, vol. 13, no. 1, pp. 92–102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. R. Schlemmer and D. G. Kaufman, “Endometrial stromal cells regulate gap-junction function in normal human endometrial epithelial cells but not in endometrial carcinoma cells,” Molecular Carcinogenesis, vol. 28, no. 2, pp. 70–75, 2000. View at Google Scholar
  21. C. S. Wun, J. F. Bechberger, W. J. Rushlow, and C. C. Naus, “Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein connexin43 in glioma cells,” Journal of Cellular Biochemistry, vol. 103, no. 6, pp. 1772–1782, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. L. S. Musil and D. A. Goodenough, “Biochemical analysis of connexin43 intracellular transport, phosphorylation, and assembly into gap junctional plaques,” Journal of Cell Biology, vol. 115, no. 5, pp. 1357–1374, 1991. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Mesnil, S. Crespin, J.-L. Avanzo, and M.-L. Zaidan-Dagli, “Defective gap junctional intercellular communication in the carcinogenic process,” Biochimica et Biophysica Acta—Biomembranes, vol. 1719, no. 1-2, pp. 125–145, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. F. McCulloch, R. Chambrey, D. Eladari, and J. Peti-Peterdi, “Localization of connexin 30 in the luminal membrane of cells in the distal nephron,” American Journal of Physiology: Renal Physiology, vol. 289, no. 6, pp. F1304–F1312, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. P. D. Lampe, E. M. TenBroek, J. M. Burt, W. E. Kurata, R. G. Johnson, and A. F. Lau, “Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication,” Journal of Cell Biology, vol. 149, no. 7, pp. 1503–1512, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. Sáez, A. C. Nairn, A. J. Czernik, G. I. Fishman, D. C. Spray, and E. L. Hertzberg, “Phosphorylation of connexin43 and the regulation of neonatal rat cardiac myocyte gap junctions,” Journal of Molecular and Cellular Cardiology, vol. 29, no. 8, pp. 2131–2145, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. T. S. Richards, C. A. Dunn, W. G. Carter, M. L. Usui, J. E. Olerud, and P. D. Lampe, “Protein kinase C spatially and temporally regulates gap junctional communication during human wound repair via phosphorylation of connexin43 on serine368,” The Journal of Cell Biology, vol. 167, no. 3, pp. 555–562, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. P. Norris, M. Freudzon, L. M. Mehlmann et al., “Luteinizing hormone causes MAP kinase-dependent phosphorylation and closure of connexin 43 gap junctions in mouse ovarian follicles: one of two paths to meiotic resumption,” Development, vol. 135, no. 19, pp. 3229–3238, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Kalma, I. Granot, D. Galiani, A. Barash, and N. Dekel, “Luteinizing hormone-induced connexin 43 down-regulation: inhibition of translation,” Endocrinology, vol. 145, no. 4, pp. 1617–1624, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Gizzo, C. Saccardi, T. S. Patrelli et al., “Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications,” Obstetrical and Gynecological Survey, vol. 68, no. 6, pp. 467–481, 2013. View at Publisher · View at Google Scholar · View at Scopus